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Thrombosis in unusual sites of the lower
extremity veins
Nicos Labropoulos, PhD, DIC, RVT,a,b Kimon Bekelis, MD,a and Luis R. Leon Jr, MD, RVT,c Stony Brook,
NY; Maywood, Ill; and Tucson, Ariz
Background: Thrombosis in unusual locations in the lower extremity veins has not been assessed. These veins are not
imaged routinely and therefore information about them is lacking.
Methods: This study was designed to evaluate the natural history of deep vein thrombosis (DVT) in unusual sites. Patients
with DVT in all thigh veins but the femoral vein were included. Patients with thrombi in any other vein in the first
examination and those with history of DVT were excluded. Duplex ultrasound (DU) examination was performed to
exclude thrombosis in the lower extremity in patients with signs and symptoms of venous thromboembolism and also in
high-risk, asymptomatic patients. All veins from the distal external iliac vein to the lower calf were imaged. The deep
femoral, femoropopliteal, lateral thigh, sciatic, and muscular thigh veins were examined. These patients were followed at
1 week, 1 month, 6 months, 1 year, and yearly thereafter, for thrombus propagation, resolution, and reflux.
Results: Among the 15,850 DU performed in the vascular laboratory at Loyola University Medical Center, in a 10-year
period to rule out DVT, 2568 (16.2%) were positive and 14 cases (7 males, 0.54% among the patients with DVT and
0.088% among the entire population) involved thromboses in unusual locations. Ten cases involved the left lower
extremity and four the right. The unusual DVT cases were associated with medical and surgical conditions or were
idiopathic in 11 patients, whereas three had Klippel-Trenaunay syndrome (KTS). The veins involved in the first group of
patients were the deep femoral (8), the femoropopliteal (2), and the deep external pudendal (1). The patients with KTS
had involvement of muscular thigh veins (1), and the lateral thigh vein and the sciatic vein (2). Thrombi propagation with
extension to the common femoral vein was seen in four of the 14 patients: two from the deep femoral vein, one from the
femoropopliteal vein, and one from the deep external pudendal vein. There were two incidences of pulmonary embolism
(PE) one of which was fatal. At final follow-up, two patients developed recurrent DVT and nine had signs and symptoms
of chronic venous disease.
Conclusions: The involvement of the studied veins in DVT is extremely rare. Thrombosis in these veins can follow the
natural course of thrombosis in the more usual locations and is associated with lethal incidences of PE. Therefore, the
association of these veins with all the grave sequelae of thromboembolic disease suggests that inclusion of these veins in
routine lower extremity duplex scans would be beneficial. ( J Vasc Surg 2008;47:1022-7.)Deep vein thrombosis (DVT) and pulmonary embo-
lism (PE) occur at an annual incidence of 1 per 1000
adults1 and has a great toll in inpatient and outpatient
morbidity and mortality. Despite the associated large costs
of DVT to society, the precise knowledge of the anatomic
distribution of venous thrombosis in “unusual locations”
such as the thigh veins has been rarely addressed. Ouriel
and colleagues2 reported that most cases of DVT are asso-
ciated with specific anatomic sites, with increasing fre-
quency from the proximal to the distal venous segments.2
However, their work and that of others have not precisely
described the occurrence of DVT in unusual sites or estab-
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1022lished their clinical significance. Our current work was
designed to provide insights into the natural history of
DVT affecting rarely reported veins in the thigh.
METHODS
Patients with thrombosis in the deep femoral and other
unusual thigh veins were included in the study. Patients
with thrombi in any other vein in the first examination and
those with a previous DVT were excluded. All these pa-
tients were referred for a duplex ultrasound (DU) exami-
nation between 1995 and 2005 to rule out thrombosis in
the lower extremity either because they had signs and
symptoms of venous thromboembolism or were asymp-
tomatic but a high risk for DVT, ie, patients that underwent
complex neurosurgery procedures.
All veins from the distal external iliac vein to the lower
calf were imaged with DU. Low flow settings with a pulse
repetition frequency 1500 Hz and color gain adjusted to
the vessel size, flow, and depth were used. Multifrequency
linear array transducers were used when the veins were
located within 6 cm depth from the skin. For veins found in
deeper locations a curvilinear 2-3 MHz array was used.
Compression in transverse view in B-mode and augmenta-
tion with color view was applied in all veins. For obese
patients and in those with significant edema, an active
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flow.
The veins examined were the deep external pudendal
vein which is seen uniting the common femoral vein oppo-
site to saphenofemoral junction. The deep femoral vein and
its tributaries were imaged from its union with the femoral
vein to at least 10 cm distally. The deep femoral vein unites
the femoral vein 2-3 cm below saphenofemoral junction to
make the common femoral vein. The third vein examined
was the femoropopliteal. This is an uncommon vein that
unites the popliteal and the deep femoral veins and is also
known as axial transformation from popliteal vein to deep
femoral vein. It is more apparent in chronic obstruction of
the femoral vein, where it dilates for compensation.3 In a
few patients, it can be seen in the absence of femoral vein
thrombosis. Other atypical veins in patients with venous
malformations were also studied. It included the lateral
thigh vein, muscular thigh veins, and the sciatic veins. The
sciatic veins could be those of the sciatic nerve or the
persistent sciatic vein which is much larger than the veins of
the nerve. When there is a sciatic vein, the femoral vein
often is hypoplastic. Because of the unusual location of
thrombosis, these patients were followed up at 1 week, 1
month, 6 months, 1 year, and yearly thereafter. They were
seen earlier if new symptoms of venous thromboembolism
were present. In case of PE symptoms a spiral CT was
performed. At follow-up, the veins were examined for
thrombus propagation, resolution, and reflux.
A second group of 100 selected patients were included
for comparison. All of them had a first episode of acute
DVT from the popliteal vein and above and were anticoag-
ulated. The involvement of the veins at unusual sites for
thrombosis was assessed. Patients with isolated calf DVT
were not included in order to match this group of patients
to our study cohort.
The CEAP classification system was used to grade the
clinical severity of the disease.4 Reflux was considered to be
present if the retrograde flow was 0.5 s in the superficial
veins, deep thigh veins, and deep calf veins; 1.0 s in the
common femoral, femoral, and popliteal veins; and0.35 s in
the perforator veins.5 Reflux was elicited was manual com-
pression distal to the site of imaging followed by sudden
release. In obese patients and those that had significant
edema, a forced dorsi-plantar flexion was performed. At the
baseline examination, the distribution and extent of throm-
bosis was recorded in detail by reporting the precise loca-
tion and length of the thrombus. This was very important
for determining the propagation and recurrence of throm-
bosis. Acute thrombus was detected by the dilatation of the
lumen, the echolucent texture, and the thin and smooth
vessel wall. The presence of chronic thrombus was deter-
mined by a normal or reduced vein diameter, the echogenic
texture, and the thick and irregular wall. During compres-
sion of the vein, the acute thrombus is spongy, and the
chronic one is firm. With the use color mode confluent flow
channels are seen in the acute thrombus compared with
multiple irregular channels in the chronic thrombus. In
addition, the fresh thrombus may have a free-floating tail.DVT propagation in the thigh veins was diagnosed when
the thrombi extended to a new vein segment, ie, from the
deep femoral to common femoral vein. Diagnosis of recur-
rent DVT was made if thrombus developed in a new
location or in a previously recanalized segment. Also, pres-
ence of echolucent material, dilation of the vein lumen of
2 mm compared with previous examination, and a double
echogenic line in the outer rim of the thrombus were used
for detecting recurrent thrombosis.6-8
These unusual vein sites are not routinely imaged and
many investigators do not even know of their existence with
the exception of the deep femoral vein. Our center has a
vast experience with the anatomy and pathology of these
veins and their study is part of the routine DU examination
of the lower extremity veins. The first author (NL) either
performed or supervised all the examinations included in
this study. Often, other ultrasound windows than the me-
dial were used to image these veins such as the lateral,
posterior-lateral, posterior, and posterior-medial. These
windows allowed better imaging and compressibility of the
veins. Anatomic landmarks such as the saphenofemoral
junction, the union of the femoral with the deep femoral
vein, the femoral bone, and the sciatic nerve were used to
locate these veins.
RESULTS
Prevalence and patient characteristics. During the
period of observation, 15,850 patients were examined in
the vascular laboratory at Loyola University Medical Center
to rule out DVT. From these patients, 2568 (16.2%) had
DVT. Thrombosis in unusual sites occurred in 14 patients
giving a prevalence of 0.088% among all patients or 0.54%
in patients with DVT. There were seven men and seven
women with a mean age of 48 13.5 years (range 26-71).
Thrombosis involved the left lower extremity in 10 patients
and the right in four. The etiology of DVT was variable
with 2 spontaneous thromboses, 2 cancer-related throm-
boses (one ovarian and one pancreatic cancer), 3 surgery-
related thromboses (2 major abdominal operations and one
thoracic spine surgery), 2 thromboses associated with mul-
tiple traumatic injuries (1 after a motor vehicle accident and
one after a fall), 2 critically ill medical patients (1 with septic
shock and one with multiple organ dysfunction syndrome),
and 3 patients with Klippel-Trenaunay syndrome (KTS).
The patients presented with signs and symptoms of DVT
(n  9) or were high-risk asymptomatic (n  5). Of the
symptomatic patients, three presented with lower extremity
pain, two had lower extremity swelling, and four had both
pain and swelling.
Distribution. The thrombi distribution was as fol-
lows: 8 cases of deep femoral vein thromboses, 2 thrombo-
ses in the femoropopliteal vein, 1 in the deep external
pudendal vein, 1 in a muscular thigh vein, and 2 patients
with thromboses in the lateral thigh vein, one of which had
associated thigh perforator vein thrombi and another with
an associated sciatic vein thrombosis (Figs 1 and 2).
Complications. Among the 14 patients, there were
three with clinical suspicion of PE, none of which belonged
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negative for PE by spiral computed tomography (CT), and
one patient died of PE, as it was later confirmed at autopsy.
One of the patients with KTS developed intestinal bleeding
for which he underwent colon resection, and he had a filter
placed in his inferior vena cava.
Follow-up. The follow-up period for the 13 patients
that were still alive varied from 11 to 37 months. From all 14
patients, 10 received anticoagulation with low-molecular or
unfractionated heparin, followed by warfarin for the therapy
of DVT immediately after the diagnosis was made. Two
patients, both with diagnosis of KTS, did not receive antico-
agulation. One of them was diagnosed with thrombus in a
muscular thigh vein, for which he was only prescribed aspirin.
The other patient developed intestinal bleeding and therefore
heparin or warfarin was considered contraindicated. A patient
with thrombus in the deep external pudendal vein did not
receive anticoagulation at the moment of DVT diagnosis.
However, on ultrasound follow-up 4 days later, extension of
thrombosis into the common femoral vein was documented
and therefore heparin was started, subsequently continued
with Warfarin. An additional patient with diagnosis of DVT
affecting the femoropopliteal vein was started on Heparin IV
immediately after her diagnosis. However, she died about 4
hours after initiation of anticoagulation due to PE found on
autopsy. At follow-up, there was thrombus propagation with
extension to the common femoral vein in 2 of the deep
femoral vein thromboses, in one of the femoropopliteal vein
thromboses and in the patient with deep external pudendal
vein thrombosis.
During the same period, recurrent DVT was observed
Fig 1. Anterior right thigh view (left panel) showing the ingui-
nal ligament (A), common femoral vein (B), deep femoral vein
(C), and the profunda-popliteal vein (D). N depicts the number
of cases identified involving deep vein thrombosis of the latter
vein segment. The right panel shows a posterior view of the
right hip and thigh, with the sciatic nerve (A) and a persistent
sciatic vein (B). Two cases of deep vein thrombosis of the
persistent sciatic vein segment were recorded.in two patients. The first patient developed ipsilateral com-mon femoral vein, femoral vein, and popliteal vein throm-
bosis at 7 months, and the second developed contralateral
calf thrombosis (soleal and peroneal veins) at 13 months of
follow-up. These patients stopped their anticoagulation
therapy at 6 months. Both patients belonged to the group
that presented initially with deep femoral vein involvement.
At final follow-up, five patients had no signs of venous
insufficiency, four presented with edema (class 3 venous
insufficiency), and one presented with skin changes (class
4). In the group of patients with KTS, two patients pre-
sented with class 4 and one with class 4-6 venous insuffi-
ciency. Four patients reported symptoms at final follow-up
in the affected limbs. One complained of burning sensa-
tion, one with burning pain and itching and two of aching.
Analysis of the comparison group. The analysis of
the second group of 100 selected patients with a first
episode of acute DVT proximal to, or including the popli-
teal vein, revealed only three cases of deep femoral vein
involvement. In all three cases, the common femoral vein
was also involved. In two of them, the femoral vein was
additionally implicated and in the remaining case, throm-
bus was also seen in the external iliac vein. These three
patients clinically presented with impressive lower extrem-
ity edema and pain, but without meeting diagnostic criteria
for phlegmasia. None of the other unusual vein segments
Fig 2. Lateral right thigh view (left panel) showing the lateral
marginal thigh vein (A), the biceps femoris muscle (B), sciatic
nerve (C), and a muscular thigh vein (D), where one case of
deep vein thrombosis was seen. Two cases of thrombosis affect-
ing the lateral marginal thigh vein were diagnosed. The right
panel shows an anterior view of the right hip and thigh, with the
deep external pudendal vein (A), the deep femoral vein
(B), femoral vein (C), knee (D), inguinal ligament (E), and the
saphenofemoral junction (F). One case of deep vein thrombosis
of the deep external pudendal vein was seen and eight affecting
the deep femoral vein. Both cases of deep external pudendal vein
were associated with thrombosis of an additional unusual seg-
ment, one involving the muscular vein depicted on the left panel
and the other affecting the deep external pudendal vein showed
on the right.reported in this group were involved.
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Lower extremity DVT has a high prevalence in hospi-
talized patients and is associated with significant short and
long-term morbidity and mortality. DVT affects 2.5 mil-
lion people annually in the United States and is associated
with 50,000 to 200,000 deaths each year.9 The magnitude
of the problem shows that DVT has a large negative impact
on human and economic resources. The standard method
to examine patients with symptoms of acute or chronic
thromboembolic disease of the lower extremity attributes
little significance to unusually affected veins of the lower
extremity. The only vein thromboses, from those studied,
for which there are reported incidences in the literature are
the ones involving the deep femoral 2,10 and the persistent
sciatic veins.11 In their study, Ouriel et al2 reported that the
prevalence of deep femoral vein thrombosis studied by
phlebography is 0.9%. However, given the fact that phle-
bography can only recognize deep femoral vein thrombosis
if there is simultaneous proximal thrombosis of the ipsilat-
eral common femoral vein or the iliac vein,3 we can infer
that the true incidence of isolated deep femoral vein throm-
bosis is much lower. Other, less frequently reported deep
veins in the thigh include the femoropopliteal vein. Raju
and colleagues3 reported, in a subset of consecutive severe
venous stasis cases, that the deep femoral vein enlarges to a
variable extent (ie, axial transformation) in some cases, to
compensate for severe post-thrombotic changes in the ac-
companying femoral vein. It is also our experience that this
vein is seen most often accompanying femoral vein throm-
bosis, but, as it is shown in the current series, this vein can
also be seen without associated femoral vein thrombi in rare
occasions. The persistent sciatic vein is a rare anomaly most
often associated with KTS.11 However, it is currently diag-
nosed with more frequency due to the improvement of
diagnostic methodologies, especially magnetic resonance
imaging. Cherry et al11 have previously described this con-
dition and identified a number of cases where PE was
associated to their presence, including lethal cases. The
persistent sciatic vein has to be carefully differentiated from
varices affecting the sciatic nerve vein.12,13 These veins are
inside the nerve and in close proximity with a smaller
diameter than the persistent sciatic vein. The deep external
pudendal14 and the lateral or marginal thigh veins15 have
been previously recognized in the literature, but no cases of
thrombosis affecting those veins have been reported up to
date. Our current work is the first report of such instances.
DVT at unusual sites in combination with axial veins is
expectedly to be much more common than isolated DVT in
unusual sites. Certainly, deep femoral vein involvement is
not rare in chronic post-thrombotic venograms. Similarly,
combined involvement intuitively would have more severe
acute and chronic symptomatology. In order to analyze
such combined involvement, a second group was included.
Our analysis indicates that the combined involvement is six
times more common and their presentation appeared to be
more severe than isolated unusual vein sites affliction. This
observation supports the argument for routine screening ofunusual vein sites, particularly the deep femoral vein, and
treating them aggressively when DVT is detected.
The patients presenting with thrombi in the unusual
locations studied in this report were both healthy individ-
uals with no significant medical history related to their
presentation and patients with severe medical and surgical
problems. These patients were selected to have thrombi in
unusual sites only, because otherwise the clinical presenta-
tion would have been affected by thrombi in the other more
usual locations, or it would have been impossible to know
where the thrombi originally started. Therefore, thrombi
do develop in these veins irrespective of the associated risk
factors for thrombosis. The natural history of the thrombo-
embolic disease in these veins mirrors that of the most
commonly observed veins. In large series, it has been
established that thrombi in the deep veins of the lower
extremities tend to propagate in 15% of the limbs16-19 and
that this tendency is associated with the morbidity and
mortality related to DVT.20,21 In our series, there was
propagation of the thrombi in four cases that involved all
the unusual veins studied.
PE is a potentially lethal complication of DVT and it
has been established that from the 100 cases of PE second-
ary to DVT only four will be clinically important and one or
two from these may be fatal.19,21 At the same time, both
the deep femoral and the persistent sciatic vein have been
associated with life threatening PE in the literature.2,10,11
In accordance with these data, in the current report, two
patients developed overt PE, which was fatal in one patient.
At follow-up, there were two patients in the study
group that presented with recurrent DVT of the lower
extremities, a finding that agrees with the reported course
of the disease in the literature. As it is expected, the cumu-
lative risk of recurrent DVT is 11% at 1 year22 and 24.3% at
5 years.23 In addition, five patients developed evidence of
post-thrombotic syndrome in concordance with the natural
course of venous thromboembolic disease in the usually
examined veins of the lower extremity, in which we expect
an incidence of post-thrombotic syndrome of 17% after 2
years.23
Besides the development of thrombosis in unusual
veins of the lower extremities in patients from the general
population, we reported the development of thrombosis in
unusual locations in patients with KTS. This syndrome is
diagnosed by the triad of varicose veins, cutaneous heman-
giomas, and hypertrophy of soft tissue and bone.24 The
existence of dysplastic blood vessels predisposes these pa-
tients’ blood to stasis, which results in an increased inci-
dence of thrombosis. Baskerville et al24 reported a 17%
incidence of radiographically proven DVT in a series of 49
patients with KTS. In comparison the incidence of autopsy
proven DVT in nonhospitalized patients is estimated to be
5%.20 In addition, the incidence of PE in patients with KTS
is estimated to be 14% to 22%.25 Therefore, DVT is a major
morbidity and mortality factor associated with this syn-
drome. In fact these patients, in accordance to what is
presented in this report, have an increased risk of develop-
ing venous insufficiency.26 The recognition of thrombosis
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and muscular thigh veins) is of heightened importance as
we prove that these veins are associated with the complica-
tions cited in the literature27 for the usually examined veins
in patients with KTS.
The literature reports thrombotic involvement of
unusual vein sites most often in association with hyper-
coagulable states. Most patients in our study had a
well-recognized risk factor for the development of a
thromboembolic event, such as a major medical illness,
recent major surgical intervention, trauma, neoplasms, or
KTS. Therefore, those patients did not undergo further
work-up for hypercoagulability. However, there were two
patients with spontaneous thrombosis, in whom decision
was left to the referring physician to pursue additional
testing, which seems intuitively advisable. Our limited data
cannot provide guidelines for when is right to perform test
for hypercoagulability. Given the rarity and the unusual
sites of thrombosis test for thrombophilia should be per-
formed until more concrete data are available.
The ideal therapy for this cohort of patients is unknown
at this time, given that the current work is the first address-
ing such cases. Most of the veins affected are considered to
be deep veins, except for the marginal thigh vein which is
superficial. However, this vein has a large diameter and
connects with multiple deep veins in the thigh and with
pelvic veins, where it usually terminates. It appears wise to
provide anticoagulation if proximal deep vein involvement
is confirmed, following the same parameters of the femoral
and popliteal vein thrombosis. It is important to note,
however, that the two events of PE in our series developed
after deep femoral vein thrombosis. Cherry and col-
leagues11 reported lethal PE cases associated with persistent
sciatic vein, which may speak of the need for anticoagula-
tion when involvement of those two veins is noted. Throm-
bosis of the remaining thigh veins was associated with PE
but as the prevalence is low and the natural history is
unknown close monitoring should be done if anticoagula-
tion is not given.
CONCLUSIONS
The prevalence of DVT of the thigh veins studied is
extremely rare. The presentation of our patients, both
initially and at follow-up, spanned the whole spectrum of
the natural history of DVT, as reported in the literature for
the more usual sites of thrombosis. Since it was not possible
to leave these patients untreated, this work reflects the
natural history of patients with treated DVT in unusual
sites. There were incidences of thrombus propagation, PE,
recurrent DVT, and post-thrombotic syndrome. The asso-
ciation of these veins with all the complications of throm-
boembolic disease suggests that imaging of these veins
would be beneficial.
AUTHOR CONTRIBUTIONS
Conception and design: NL, KB, LL
Analysis and interpretation: NL, KB, LL
Data collection: NL, KB, LLWriting the article: NL, KB, LL
Critical revision of the article: NL, LL
Final approval of the article: NL, KB, LL
Statistical analysis: Not applicable
Obtained funding: Not applicable
Overall responsibility: NL
REFERENCES
1. Cushman M. Epidemiology and risk factors for venous thrombosis.
Semin Hematol 2007;44:62-9.
2. Ouriel K, Green RM, Greenberg RK, Clair DG. The anatomy of deep
venous thrombosis of the lower extremity. J Vasc Surg 2000;31:895-
900.
3. Raju S, Fountain T, Neglen P, Devidas M. Axial transformation of the
profunda femoris vein. J Vasc Surg 1998;27:651-9.
4. Eklof B, Rutherford RB, Bergan JJ, Carpentier PH, Gloviczki P, Kistner
RL, et al. Revision of the CEAP classification for chronic venous
disorders: consensus statement. J Vasc Surg 2004;40:1248-52.
5. Labropoulos N, Tiongson J, Pryor L, Tassiopoulos AK, Kang SS, Ashraf
Mansour M, et al. Definition of venous reflux in lower extremity veins.
J Vasc Surg 2003;38:793-8.
6. Labropoulos N, Tassiopoulos AK. Vascular diagnosis of venous throm-
bosis. In: Mansour MA, Labropoulos N, editors. Vascular diagnosis.
Philadelphia, PA: Elsevier Saunders; 2005 pp. 429-38.
7. Prandoni P, Cogo A, Bernardi E, Villalta S, Polistena P, Simioni P, et al.
A simple ultrasound approach for detection of recurrent proximal-vein
thrombosis. Circulation 1993;88:1730-5.
8. Linkins LA, Pasquale P, Paterson S, Kearon C. Change in thrombus
length on venous ultrasound and recurrent deep vein thrombosis. Arch
Intern Med 2004;164:1793-6.
9. Weinmann EE, Salzman EW. Deep venous thrombosis. N Engl J Med
1994;331:630-41.
10. Habscheid W. Isolated thrombosis of the vena profunda femoris as the
source of embolisms. A diagnosis easy to supply using duplex sonogra-
phy. Dtsch Med Wochenschr 1999;124:793-6.
11. Cherry KJ, Gloviczki P, Stanson AW. Persistent sciatic vein: diagnosis
and treatment of a rare condition. J Vasc Surg 1996;23:490-7.
12. Ricci S, Georgiev M, Jawien A, Zamboni P. Sciatic nerve varices. Eur J
Vasc Endovasc Surg 2005;29:83-7.
13. Tassiopoulos AK, Labropoulos N, Gasparis AP, Pappas PJ, Ricotta JJ.
Veins along the course of the sciatic nerve. Proceedings of the 19th
Annual meeting of the American Venous Forum, San Diego, CA,
February 14-17, 2007.
14. Donnelly M, Tierney S, Feeley TM. Anatomical variation at the saphe-
nofemoral junction. Br J Surg 2005;92:322-5.
15. Rojas Martinez R, Puech-Leao P, Guimaraes PM, Netto BM. Persis-
tence of the embryonic lateral marginal vein: report of two cases. Rev
Hosp Clin Fac Med Sao Paulo 2001;56:159-62.
16. Kakkar VV, Howe CT, Flanc C, Clarke MB. Natural history of postop-
erative deep-vein thrombosis. Lancet 1969;2:230-2.
17. Lagerstedt CI, Olsson CG, Fagher BO, Oqvist BW, Albrechtsson U.
Need for long-term anticoagulant treatment in symptomatic calf-vein
thrombosis. Lancet 1985;2:515-8.
18. Philbrick JT, Becker DM. Calf deep venous thrombosis: a wolf in
sheep’s clothing? Arch Intern Med 1988;148:2131-8.
19. Sevitt S, Gallagher N. Venous thrombosis and pulmonary embolism: a
clinico pathological study in injured and burned patients. Br J Surg
1961;48:475-89.
20. Nordstrom M, Lindblad B. Autopsy verified venous thromboembolism
within a defined urban population: the city of Malmo, Sweden. APMIS
1998;106:378-84.
21. Collins R, Scrimgeour A, Yusuf S, Peto R. Reduction in fatal
pulmonary embolism and venous thrombosis by perioperative ad-
ministration of subcutaneous heparin: overview of results of random-
ized trials in general, orthopedic, and urologic surgery. N Engl
J Med 1988;318:1162-73.
22. Prandoni P, Noventa F, Ghirarduzzi A, Pengo V, Bernardi E, Pesavento
R, et al. The risk of recurrent venous thromboembolism after discon-
JOURNAL OF VASCULAR SURGERY
Volume 47, Number 5 Labropoulos et al 1027tinuing anticoagulation in patients with acute proximal deep vein
thrombosis or pulmonary embolism. A prospective cohort study in
1626 patients. Haematologica 2007;92:199-205.
23. Prandoni P, Villalta S, Bagatella P, Rossi L, Marchiori A, Piccioli A, et al.
The clinical course of deep-vein thrombosis. Prospective long-term
follow-up of 528 symptomatic patients. Haematologica 1997;82:423-8.
24. Baskerville PA, Ackroyd JS, Lea Thomas M, Browse NL. The Klippel-
Trenaunay syndrome: clinical, radiological and hemodynamic features
and management. Br J Surg 1985;72:232-6.
25. Gianlupi A, Hareper RW, Dwyre DM, Marelich GP. Recurrent pulmo-
nary embolism associated with Klippel-Trenaunay-Weber syndrome.26. Delis KT, Goviczki P, Wennberg PW, Rooke TW, Driscoll DJ.
Hemodynamic impairment, venous segmental disease and clinical
severity in limbs with Klippel-Trenaunay syndrome. J Vasc Surg
2007;45:561-7.
27. Muluk SC, Ginns LC, Semigran MJ, Kaufman JA, Gertler JP.
Klippel-Trenaunay syndrome with multiple pulmonary emboli-an
unusual cause of progressive pulmonary dysfunction. J Vasc Surg
1995;21:686-90. Chest 1999;155:1199-201. Submitted Aug 3, 2007; accepted Dec 16, 2007.
RECOUP THE LOUPES 
Despite extremely limited resources, surgeons in developing countries work to provide their 
patients with the best possible care. For many of these surgeons, technology such as loupes, 
which facilitate delicate procedures, is simply out of reach.  
One year ago, Loupes Around The World distributed its first pair of loupes to a plastic surgeon
in Phnom Penh, Cambodia. Before Loupes Around The World, this surgeon commonly 
repaired cleft lips and palates, and treated trauma patients with maxillofacial injuries without 
the benefit of surgical magnification. Since then, this not-for-profit organization has provided 
loupes to surgeons from Panama to India and continues to receive requests from surgeons 
around the world.  
Loupes Around The World is now recycling donated loupes via a program called “Recoup the 
Loupes.” Surgeons with unused loupes are asked to send them to the foundation; there, repairs 
can be made to adjustable loupes, and the telescopes from fixed loupes can be installed into 
new lenses and frames. For fixed loupes, optical measurements are taken to ensure that the 
loupes will meet the needs of each individual surgeon. 
Please send your unused loupes to:  
David C. Knight, M.D., F.A.C.S. 
Loupes Around The World 
c/o Surgical Associates of Waterbury 
1211 West Main St. 
Waterbury, CT 06708 
Loupes Around The World accepts loupes made by any manufacturer. For more information 
about Loupes Around The World, as well as information about how to contribute, please visit: 
www.loupesaroundtheworld.org. Upon receiving loupes, a letter of acknowledgment will be 
sent to the donor for tax purposes. Loupes Around the World is a 501(c)3 tax-exempt 
organization.  
